Indeed, FYN-TRAF3IP2-dependent lymphoma cells display exquisite sensitivity to the BCL-XL, BCL2 and BCL-W (encoded by Bcl2l2) inhibitor ABT-263. This evidence concerns the gene BCL2L2 and lymphoma.